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Abstract
AIM: to investigate studies conducted with the Mood 
Spectrum Structured Interviews and Self-Report versions 
(SCI-MOODS and MOODS-SR).
METHODS: We conducted a review of studies published 
between 1997 and August 2014. The search was 
performed using Pubmed and PsycINFO databases. 
Analysis of the papers followed the inclusion and exclusion 
criteria recommended by the PRISMA Guidelines, namely: 
(1) articles that presented a combination of at least two 
terms, “SCI-MOODS” [all fields] or “MOODS-SR” [all 
fields] or “mood spectrum” [all fields]; (2) manuscript 
in English; (3) original articles; and (4) prospective or 
retrospective original studies (analytical or descriptive), 
experimental or quasi-experimental studies. Exclusion 
criteria were: (1) other study designs (case reports, 
case series, and reviews); (2) non-original studies 
including editorials, book reviews and letters to the 
editor; and (3) studies not specifically designed and 
focused on SCI-MOODS or MOODS-SR.
RESULTS: The search retrieved 43 papers, including 
5 reviews of literature or methodological papers, and 1 
case report. After analyzing their titles and abstracts, 
according to the eligibility criteria, 6 were excluded and 
37 were chosen and included. The SCI-MOODS and 
the MOODS-SR have been tested in published studies 
involving 52 different samples across 4 countries (Italy, 
United States, Spain and Japan). The proposed mood 
spectrum approach has demonstrated its usefulness 
mainly in 3 different areas: (1) Patients with the so-
called “pure” unipolar depression that might manifest 
hypomanic atypical and/or sub-threshold aspects 
systematically detectable with the mood questionnaire; 
(2) Spectrum features not detected by other instruments 
are clinically relevant, because they might manifest 
in waves during the lifespan, sometimes together, 
sometimes alone, sometimes reaching the severity 
for a full-blown disorder, sometimes interfering with 
ORIGINAL ARTICLE
Submit a Manuscript: http://www.wjgnet.com/esps/
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
DOI: 10.5498/wjp.v5.i1.126
World J Psychiatr  2015 March 22; 5(1): 126-137
ISSN 2220-3206 (online)
© 2015 Baishideng Publishing Group Inc. All rights reserved.
World Journal of 
PsychiatryW J P
126 March 22, 2015|Volume 5|Issue 1|WJP|www.wjgnet.com
Retrospective Study
other mental disorders or complicating the course of 
somatic diseases; and (3) Higher scores on the MOODS-
SR factors assessing “psychomotor disturbances”, 
“mixed instability” and “suicidality” delineate subtypes 
of patients characterized by the more severe forms of 
mood disorders, the higher risk for psychotic symptoms, 
and the lower quality of life after the remission of the 
full-blown-episode.
CONCLUSION: The mood spectrum model help researchers 
and clinicians in the systematic assessment of those 
areas of psychopathology that are still neglected by the 
Diagnostic and Statistical Manual of Mental Disorders 5 
classification. 
Key words: Mood disorders; Dimensional; Categorical; 
Unipolar; Spectrum; Bipolar; Diagnostic and Statistical 
Manual of Mental Disorders 5
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Data emerging from the proposed mood 
spectrum approach suggest the existence of a continuum 
from “pure mania” to “pure depression”, without a 
clear cut-off between the two realms. As a whole, the 
experience with the mood spectrum model enforces 
past and recent claims towards the need for a unitary 
dimensional approach to mood disorders. 
Benvenuti A, Miniati M, Callari A, Giorgi Mariani M, Mauri M, 
Dell’Osso L. Mood Spectrum Model: Evidence reconsidered 
in the light of DSM-5. World J Psychiatr 2015; 5(1): 126-137 
Available from: URL: http://www.wjgnet.com/2220-3206/full/
v5/i1/126.htm  DOI: http://dx.doi.org/10.5498/wjp.v5.i1.126
INTRODUCTION
The boundaries of mood disorders have expanded 
during the last two decades as a consequence of the 
growing interest in the atypical, subclinical and/or sub-
threshold forms of unipolar and bipolar disorders[1,2]. 
Efforts were initially devoted to the identification 
of atypical and sub-threshold forms of depression 
(Depressive Spectrum)[3,4]. Subsequently, the manic/
hypomanic side was explored[1,5,6] giving a new impulse 
to the literature on mood disorders in general. 
An enlargement of the manic dimension of mood 
disorders was thus proposed, aiming to identify those 
bipolar syndromes that, not fitting in the classic 
categorical description of Diagnostic and Statistical 
Manual of Mental Disorders (DSM), have led to an 
over-diagnosis of “pure” unipolar forms[7]. However, 
the unipolar/bipolar dichotomy was still maintained as 
nuclear to all the proposed theoretic constructs.
At the beginning of the 90’s, in an attempt to define 
“soft indicators of bipolarity”, the focus was shifted on 
affective temperaments[8]. Over the following years, 
clinicians and researchers of the University of Pisa, 
Italy, and of the Universities of Pittsburgh, Columbia 
(New York) and California (San Diego), promoted 
the “Spectrum Project Collaborative Group” (SPCG) 
whose aim was to create and validate instruments 
able to recognize the wide halo of phenomenology 
surrounding the “core” features of each DSM mood 
category and overcome the classic unipolar/bipolar 
dichotomy[9]. 
The SPCG research agenda was based upon the 
empirical observation that a wide range of signs and 
features not included in the DSM might run completely 
overlooked or simply be considered not relevant 
from a clinical point of view. Conversely, a growing 
body of evidence indicated the clinical relevance 
of sub-threshold or atypical presentations of mood 
disorders and the potential usefulness of a dimensional 
assessment[9]. 
The SPCG proposed that life-long sub-threshold 
mood dysregulations represented the constitutional 
foundation of both full-blown manic and depressive 
episodes. The “SCI-MOODS” and the “its self-report 
version” (MOODS-SR) were developed to assess this 
wide area of phenomenology. The SCI-MOODS was the 
first version of the questionnaire, the MOODS-SR being 
its self-report version. The same authors constructed a 
MOODS-SR last-month version. All the versions were 
developed in parallel in English and Italian with a back 
translation and a subsequent validation for internal 
consistency and inter-rater reliability. The instruments 
consisted of 161 items coded as present or absent 
for one or more periods of at least 3-5 d through the 
subject’s lifetime or over the past week or month[10]. 
The MOODS-SR was originally composed of four 
domains: (1) The Neurovegetative domain, assessing 
disturbances and rhythmic changes in feelings, eating 
attitudes, sexual activity and sleep, including rhythmic 
variations in affective and sub-affective symptoms; 
(2) the Energy levels domain, assessing changes in 
everyday activities, with special attention devoted to 
work, hobbies and social life; (3) the mood Domain, 
exploring the whole realm of depressive and manic 
symptoms, signs and sub-threshold manifestations of 
mood dysregulations; and (4) The cognitive domain, 
assessing changes in the cognitive realm that occur 
together with mood dysregulations[11]. 
The potential implications and the conceptual and 
methodological advantages of the proposed mood 
spectrum model have been already described[9-12]. 
However, at that time, evidence from clinical studies 
using the SCI-MOODS and the MOODS-SR was limited. 
The aim of this paper is to review and summarize 
the studies conducted with the SCI-MOODS and the 
MOODS-SR over the past 15 years and reconsider the 
evidence in the light of the DSM-5.
MATERIALS AND METHODS
We conducted a review of studies published between 
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1997 (year of the first publication regarding the 
proposed mood spectrum approach) and August 2014. 
The search was performed using Pubmed and PsycINFO 
databases. Analysis of the articles followed inclusion and 
exclusion criteria derived from the ones recommended 
by the PRISMA Guidelines[13]. We included the following: 
(1) articles that presented a combination of at least two 
terms, namely “SCI-MOODS” [all fields] or “MOODS-
SR” [all fields] or “mood spectrum” [all fields]; (2) 
manuscript in English; (3) original articles; and (4) 
prospective or retrospective original studies (analytical 
or descriptive), experimental or quasi-experimental. 
Exclusion criteria were as follows: (1) other study 
designs, such as case reports, case series, and reviews; 
(2) non-original studies including editorials, book 
reviews and letters to the editor; and (3) studies not 
specifically designed and focused on SCI-MOODS or 
MOODS-SR. 
We utilized a flow diagram (Figure 1) to summarize 
the total number of screened papers and the number 
of those included in the review process, as suggested 
by the PRISMA Guidelines[13]. No extraction forms for 
the data extraction process were used, mainly because 
the studies on the proposed mood spectrum model 
were conducted in different fields and with different 
aims, as described in detail in the paragraphs of the 
result section. Two authors completed a formal training 
in reviewing data and performing meta-analyses, 
independently from this manuscript (AC and MGM). 
Initially, the search retrieved 43 papers, including 
5 reviews of literature or methodological papers, and 1 
case report. After analyzing their titles and abstracts, 
according to the eligibility criteria, 6 were excluded 
and 37 were chosen and included in the final sample 
(Figure 1).
Statistical analysis
No new data have been added in this paper. No new 
analyses or meta-analyses were performed. The 
description of statistical methods used in any study 
can be found in the related papers.
RESULTS
The SCI-MOODS and the MOODS-SR have been tested 
in published studies involving 52 samples across 4 
countries (Italy, United States, Spain and Japan) (see 
Table 1).
The SCI-MOODS and the MOODS-SR: Validity and 
reliability
The first two studies with the SCI-MOODS tested its 
validity and reliability. The reliability of the interview 
was proved to be excellent: the inter-rater reliability 
of domains ranged between 0.93 and 0.94, and the 
internal consistency of domains ranged between 0.79 
and 0.92. In terms of discriminant validity, patients 
with mood disorders had significantly higher total and 
MOODS domain scores than controls, and patients 
with a bipolar disorder scored significantly higher on 
the manic component than patients with unipolar 
depression[10,14]. Subsequently, the self-report version 
of the questionnaire, the MOODS-SR, was developed 
and validated[11]. The results of the validation study 
were partially replicated by Ghouse et al[15]. Berrocal 
et al[16] validated a Spanish version of the MOODS-
SR. A Swedish version of the questionnaire is currently 
undergoing the validation process. 
A second step was the attempt to give the MOODS-
SR a post-hoc structure with a factor analysis. The 
aim of the factor analysis was to determine, with 
a statistical approach, factors able to differentiate 
the pure dimensions of the depressive and the 
manic realm. The first study focused on the factor 
structure of mania-hypomania. The MOODS-SR was 
administered to a sample of 617 patients with a bipolar 
I disorder, diagnosed with the SCID-I. A classical 
exploratory factor analysis, based on a tetra choric 
matrix, was carried out on the 68 items of the manic/
hypomanic component, followed by an Item Response 
Theory (IRT)-based factor analytic approach and by an 
IRT-based bi-factor analysis. Five factors of the manic/
hypomanic component were identified: “Psychomotor 
Activation”, “Mixed Instability”, “Spirituality/Mysticism/
Psychoticism”, “Mixed Irritability” and “Euphoria”. This 
approach permitted to subtype two clinical phenotypes 
of mania: the “pure mania”, characterized by typical, 
atypical and sub-threshold symptoms of euphoria 
and psychomotor activation, and the “mixed mania”, 
characterized by instability and irritability[17]. In a 
second study, the clinical features of 598 patients 
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Literature search
Databases: PubMed and PsycINFO
Search terms: SCI-MOODS [MeSH term], MOODS-SR [MeSH term], mood 
spectrum [MeSH term]
Limits: English language articles only, Full papers, Original articles, 
prospective or retrospective original studies (analytical or descriptive), 
experimental or quasi-experimental
Articles screened on the basis or title and abstract
Search results combined (n  = 43)
Manuscripts review and application of exclusion criteria
Excluded n  = 6: reviews or methodological papers (n  = 5), case report (n  
= 1)
Included n  = 37
Figure 1  Flow diagram of study selection. SCI-MOODS: Mood Spectrum 
Structured Interview; MOODS-SR: MOODS Spectrum self-report version.
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Benvenuti A et al . Mood Spectrum Model evidence reconsidered
The detection of lifetime mood spectrum signs and 
symptoms among patients with other DSM-IV diagnoses 
and/or somatic/physical conditions
Benvenuti et al[20] assessed patients with borderline 
personality disorder with and without a comorbid mood 
disorder. The depressive and the manic-hypomanic 
component of the mood spectrum were higher than 
in normal controls and significantly correlated with 
the presence of sub-threshold psychotic symptoms, 
as assessed with the the Structured Clinical Interview 
for the Psychotic Spectrum (SCI-PSY) also in those 
patients who did not meet criteria for a DSM-5 diagnosis 
for a mood disorder[20]. Patients with borderline 
personality disorder and a comorbid mood disorder 
showed an even stricter correlation between the 
manic/hypomanic component of the MOODS-SR and 
different domains and sub-domains of the SCI-PSY[20]. 
These results were partially replicated by Berrocal et 
al[21], in a following study with the Spanish version 
of the questionnaire[21]. In a more recent paper 
Apfelbaum et al[22] tested the MOODS-SR in patients 
with Bipolar disorders with and without a comorbid 
Cluster B personality disorder. The results of the study 
showed that patients with BD + PD-B comorbidity had 
an earlier onset and more severity in suicide attempts, 
hospitalizations and self-harm behaviors[22].
More recently Apfelbaum et al[22] and Dell’Osso et 
al[23-25] has explored the role of mood dysregulations 
in patients with complicated grief (CG) and/or Post 
Traumatic Stress Disorder (PTSD) without full-blown 
mood disorders[22-25]. The aims of these studies were 
to better characterize patients in the perspective of 
a more tailored treatment approach, and to identify 
vulnerability towards CG and PTSD. Patients were 
assessed with the MOODS-SR lifetime version. MOODS-
SR scores were higher in patients with CG than in 
controls. Patients with CG in comorbidity with PTSD 
and patients with PTSD reported significantly higher 
scores on the manic component of the MOODS-
SR than patients with CG alone[26,27]. Patients with 
PTSD and higher MOODS-SR scores showed a higher 
likelihood of suicidal ideation or attempts[28]. In a 
following study, the same research group tested the 
18 kDa mitochondrial translocator protein (TSPO) 
density in a sample of patients with a non-war-
related PTSD. The decrease of TSPO correlated 
with the manic/hypomanic component of the mood 
spectrum, suggesting a possible role of sub-threshold 
bipolar comorbidity in PTSD-related neurobiological 
dysregulations[29]. These studies proved the ability 
of the MOODS-SR to detect sub-threshold manic/
hypomanic signs in psychiatric patients without a 
full-blown diagnosis of Bipolar Disorder. The manic/
hypomanic dimension as assessed with the MOODS-
SR was associated with greater severity, higher risk 
for a psychotic evolution and higher suicidal risk in 
patients without a mood disorder. 
The MOODS-SR has proved its usefulness also 
in medical settings and in non-psychiatric samples. 
Patients with fibromyalgia showed a relationship 
between the MOODS-SR lifetime manic spectrum 
scores, severity of pain and health-related quality of 
life[30]. Not surprisingly, lifetime depressive spectrum 
symptoms negatively affected quality of life in patients 
with rheumatoid arthritis (RA) while sub-threshold 
manic features improved the subjective perception 
of health[31,32]. Sub-threshold depressive symptoms 
were over-represented in fibromyalgic patients as 
compared to RA patients[33,34]. The mood spectrum 
instruments were also utilized to detect subthreshold 
mood dysregulations among patients with temporo-
mandibular disorders or bruxism[35-39]. Hardoy et 
al[40] tested the instrument among subjects during 
the premenstrual phase showing that mixed features 
correlate with levels of allopregnanolone and pro-
gesterone.
Mauri et al[41] published a large study performed 
to assess suicidality in a non-clinical sample of 1066 
subjects during the perinatal period and to report 
suicidality rates in women with major or minor 
depressive episode (MmD). Subjects were screened 
with the SCID, during the perinatal period and with the 
MOODS-SR. The period prevalence of suicidality was 
6.9% (95%CI: 6.0-7.8) during pregnancy and 4.3% 
(95%CI: 3.4-5.2) during postpartum, assessed with 
the MOODS-SR, and was 12.0% (95%CI: 10.8-13.2) 
during pregnancy and 8.6% (95%CI: 7.4-9.8) during 
the postpartum period, assessed with the EPDS. The 
prevalence of suicidality in women who had MmD 
during pregnancy was 26.4% and 34.1%, assessed 
with the MOODS-SR and the EPDS, respectively, while 
it was 18.4% (MOODS-SR) and 30.6% (EPDS) during 
the postpartum period.
Sub-typing clinical phenotypes of Mood Disorders: The 
“Depression Phenotype Study” 
The Depression phenotypes study was a multi-center 
study financed by NIMH grants (Grant number: 
MH65376; MH30915) and performed by the University 
of Pittsburgh and Pisa. Aim of the study was to 
identify the mediators and moderators of depression 
treatment outcomes. Patients with a non-psychotic 
major depressive episode were randomly assigned to 
a pharmacotherapeutic intervention (escitalopram) 
or to the Interpersonal Psychotherapy (IPT), an 
empirically validated manual-based treatment for major 
depression. If the initial treatment was not successful 
in bringing about remission (HAM-D < 7), subjects 
received the other treatment as add-on. Patients were 
administered several instruments including the MOODS-
SR in its lifetime and last-month versions. 
Miniati et al[42] showed that in patients who reached 
remission according to the Hamilton Rating Scale for 
Depression, scores on the depressive component of the 
MOODS-SR predicted relapses in the subsequent 6 mo. 
The same authors analyzed patients belonging to the 
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Depression phenotypes study with a history of emotional 
and physical abuse. The two groups differed on several 
mood spectrum factors, namely: “depressive mood”, 
“psychomotor retardation”, “drug and illness-related 
depression”, and “neurovegetative symptoms”[43].
Patients with lower scores on the “psychomotor 
activation” factor of the MOODS-SR experienced a 
shorter time to remission when treated with SSRIs 
compared to IPT[43]. Subsequent analyses indicated that 
7 of 9 (77.8%) patients who experienced hypomania 
during the study had psychomotor activation scores 
above the median (≥ 5), suggesting that this factor 
might be useful for the identification of patients at high 
risk of switching[44]. 
Depressive mood, suicidality, psychomotor retard-
ation, neurovegetative symptoms, and the psychotic 
features factors of the MOODS-SR resulted as non-
specific predictors of longer time to remission when in 
monotherapy[44]. 
Benvenuti et al[45] assessed the quality of life and 
the functional impairment of those patients who 
reached remission in the above-mentioned sample. 
In a previous study Fagiolini et al[46] proved the 
usefulness of MOODS-SR in detecting depressive 
sub-threshold manifestations that cause functional 
impairment in a sample of patients with bipolar 
disorder in remission. Patients with unipolar depression 
showed a poorer quality of life associated with the 
MOODS-SR factors “depressive mood” and “psychotic 
features”. Higher functional impairment was associated 
with the MOODS-SR factor “psychomotor retardation”. 
These data confirmed the ability of the MOODS-SR in 
recognizing subtle signs and symptoms not detected 
by the usual rating scales (namely HAM-D), but which 
interfere with the subjective perception of quality of life 
and functioning. 
These results confirmed the hypothesis that a 
better definition of clinical phenotypes should be a 
crucial factor in the decision-making process for more 
specific and effective treatment strategies for the so-
called pure unipolar depression.
In a following study, the hypothesis that “retardation” 
could be at the same time an indicator of clinical 
severity of depression and a “validator” of a bipolar 
diathesis in unipolar patients was tested[47], in line with 
previous observations in this field[48-51]. 
Unipolar patients with higher scores on the lifetime 
psychomotor retardation factor of the MOODS-SR 
showed greater severity of depression and more 
bipolar indicators, namely: earlier age at onset, longer 
duration of illness, higher frequency of episodes, more 
lifetime suicide attempts and a positive family history 
of psychiatric disorders. These patients were also 
more likely to endorse sub-threshold bipolar features, 
as assessed by the MOODS-SR, such as “Mixed 
Irritability”, “Mixed Instability” and “Creativity”.
Starting from a neurobiological point of view, 
Rucci et al[52] analyzed the relationship between the 
polymorphisms of 5-HTTLPR genotype and the MOODS-
SR manic-hypomanic component over the lifetime. 
The authors found that the association between the 
manic/hypomanic component of the MOODS-SR and 
the polymorphisms of the 5-HTTLPR was moderated 
by gender. Moreover, women with unipolar disorder 
and the “ss” genotype were characterized by a higher 
severity of depression[52]. 
The detection of subjects with the so-called “pure” 
Unipolar Depression who are at risk for a Bipolar 
Disorder: The Classification-Tree approach
An exploratory statistical approach based on a 
classification tree analysis was used with the aim to 
determine which combination of clinical, demographic, 
and psychopathological factors and corresponding 
cut-off scores could best discriminate patients with 
unipolar disorder from those with bipolar disorders. 
Data were extracted from a database of 1158 patients 
tested with the MOODS-SR in the United States and 
Italy between October 2001 and March 2008. Patients 
received a DSM-Ⅳ-TR diagnosis of unipolar or bipolar 
mood disorders as assessed with the SCID-I. The 
classification tree utilized 5 mania spectrum factors 
and 6 depression spectrum factors derived from the 
MOODS-SR in combination with demographic and 
clinical characteristics. The psychomotor activation 
factor, assessing the presence of thought acceleration, 
distractibility, hyperactivity and restlessness for 1 
or more periods of at least 3 to 5 d in the lifetime, 
identified subgroups with an increasing likelihood 
of bipolar disorder diagnosis. Mixed instability and 
suicidality contributed to further sub-typing the sample 
into mutually exclusive groups, characterized by a 
different likelihood of a diagnosis of bipolar disorder. 
Only gender proved to be useful to improve the 
discrimination, among the overall set of demographic 
and clinical characteristics included in the analysis[53]. 
DISCUSSION
The MOODS-SR has demonstrated its usefulness in 
different fields. Patients with the so-called unipolar 
depression manifest hypomanic atypical and/or sub-
threshold aspects that are detectable with the mood 
questionnaire. Spectrum features, as assessed with 
the MOODS-SR, might manifest in waves during the 
lifespan, presenting sometimes together, sometimes 
alone, sometimes reaching the severity for a full-
blown disorder, sometimes interfering with other 
mental disorders or complicating the course of somatic 
diseases. Higher scores on the factors assessing 
psychomotor disturbances, mixed instability and 
suicidality delineate specific subtypes of patients 
characterized by a more severe form, a higher risk for 
psychotic symptoms, and a lower quality of life after 
remission.
Clinical observations have shown that psychomotor 
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activation and irritability characterized mixed 
depression in 33% to 47% of patients with mood 
disorders[54-56]. On the other hand, some of the DSM-5 
mixed features are rarely present in mixed states[57]. 
As a whole, the new classification does not clarify the 
overlap between unipolar and bipolar depression[58]. 
The DSM-5 authors added a “mixed features” specifier 
in patients with manic, hypomanic and depressive 
episode, thus recognizing the importance of soft 
bipolar signs in depressive patients and the typical 
instability of these manifestations (symptoms have to 
be present “nearly” every day). This notwithstanding, 
DSM-5 considers as “mixed features” only those sub-
threshold symptoms of depression and mania that do 
not overlap. This definition permits the inclusion of 
seven symptoms as representative of “mixed features”. 
As a result, psychomotor agitation, irritability and 
distractibility have been excluded, leading to a clinical 
construct that does not fit the whole realm of clinical 
reality[57,59]. Our studies with the MOODS-SR performed 
on unipolar patients confirmed and highlighted 
the complexity of the mixed dimension. The whole 
realm of the manic/hypomanic manifestations could 
appear in patients with unipolar depression and their 
assessment during the entire lifetime is crucial for their 
definition. 
As a whole, the experience with our instruments 
enforces past and recent claims towards the need for a 
dimensional approach to mood disorders[2,5,60,61]. 
Thus, data emerging from the mood spectrum 
approach suggest the existence of a continuum from 
“pure mania” to ”pure depression”, without a clear cut-
off between the two realms, confirming the need for a 
probabilistic approach towards mood disorders[60,62]. 
Several observations already highlighted the need 
of a more refined assessment of the broader area 
of psychopathology surrounding the core features of 
mood disorders in a dimensional manner. For example, 
studies with the Multidimensional Assessment of 
Thymic States (MAThyS) focused on the processes 
of inhibition/activation in 5 different dimensions 
(emotional reactivity, cognition speed, psychomotor 
function, motivation and sensory perception)[63], 
while the TEMPS-A[64] assessed the classical Akiskal’
s affective temperaments[65,66]. Conversely, the 
DSM-5 task force for mood disorders decided that 
the unipolar/bipolar dichotomy would better fit for 
a diagnostic manual, which major aim is to help 
clinicians and researchers in the diagnostic process. 
The authors of the DSM-5 undoubtedly made an effort 
towards the “dimensional” realm, enlarging the too 
strictly designed categories of the DSM-Ⅳ, adding a 
number of subcategories and several specifiers for 
each diagnosis. The implementation of mood disorders 
with the “other specified” and “unspecified” categories 
represents an attempt to give clinical significance to 
atypical and sub-threshold manifestations of mood 
disorders. The description of previously neglected 
features (such as hopelessness) among the diagnostic 
criteria of depression moves in the same direction. 
This effort towards a more refined description of mood 
dimensions enlarged the number of subcategories (now 
14) through a complex combination of coded courses 
and severity specifiers mimicking a dimensional rating. 
As far as we know, the MOODS-SR is the only 
instrument exploring the “core” criterion diagnostic 
symptoms and their associated features, as well 
as the wide range of symptoms surrounding the 
typical features of mania and depression, in a unitary 
format. Findings suggest that the mood spectrum 
approach is able to offer clinicians a more clinically 
meaningful assessment of psychopathology than 
the established measures of manic and depressive 
severity. We propose the SCI-MOODS as an advance 
in clinical and research methodology. Unfortunately, 
even if the change in DSM-5 pointed-out for a more 
subtle definition of mood disorders a wide area of 
mood spectrum psychopathology is still neglected. 
The dimensional revolution in DSM-5 did not happen. 
Recalling Zenone’s paradox, we can continuously 
reduce the distance between subcategories but we 
will never create a continuum. As a consequence a 
wide realm of psychopathology is still unexplored, 
unrecognized and not yet coded. The mood spectrum 
approach could help in the assessment of these 
neglected features by filling the DSM-5 gaps of the 
categorical approach.
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